 
	
	
	
		
			
			
		
		
			
			
				 
			
			
			
			
			
			
			
				May 12, 2020			
			
			
			As unemployment rates soar to record highs, patients face new health care access challenges. 
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				May 11, 2020			
			
			
			The novel coronavirus may be propelling Cures 2.0 efforts to the forefront.
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				May 7, 2020			
			
			
			Prior authorization was once a commonsense safeguard.  But that is no longer the case. 
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				May 5, 2020			
			
			
			It’s rare for a rare disease to have an FDA-approved treatment.  Yet transthyretin amyloidosis, a complex disease caused by improper protein build-up, has three. 
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				April 30, 2020			
			
			
			In early March, long-term care facilities such as nursing homes started to sound the alarm.  
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				April 28, 2020			
			
			
			Years after a cure became available for hepatitis C, infections are skyrocketing. 
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				April 28, 2020			
			
			
			The threat of the coronavirus was bad enough. 
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				April 27, 2020			
			
			
			A newly FDA-approved medication reflects how ongoing research continues to improve the treatment of Parkinson’s disease. 
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				April 27, 2020			
			
			
			COVID-19 has made ventilator access a front-page issue. But for patients with chronic respiratory conditions, especially Medicare beneficiaries, the challenge is hardly a new one. 
			
		
		
		
							
				
	
		
		
			
			
				 
			
			
			
			
			
			
			
				April 24, 2020			
			
			
			I’ve never forgotten the story.  It came from a man in a focus group I once conducted on irritable bowel syndrome.